Stay updated with breaking news from Joana sabat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Barcelona, Spain - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global leader in plasma medicines, has started marketing XEMBIFY®, its 20% subcutaneous immunoglobulin, in Spain. This plasma medicine is indicated for treating primary immunodeficiencie. ....